Alpha Q Advisors LLC Merck & Co., Inc. Transaction History

Alpha Q Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 02, 2024	BUY	$113.24 - $131.95 $42,578 - $49,613	376 Added 5.47%	7,249 $957 Million
Q4 2023 Jan 29, 2024	SELL	$100.18 - $109.02 $19,134 - $20,822	-191 Reduced 2.7%	6,873 $749 Million
Q3 2023 Oct 27, 2023	SELL	$102.95 - $114.33 $90,698 - $100,724	-881 Reduced 11.09%	7,064 $727 Million
Q2 2023 Aug 08, 2023	BUY	$108.61 - $118.38 $62,993 - $68,660	580 Added 7.88%	7,945 $917 Million
Q1 2023 May 15, 2023	SELL	$102.94 - $114.86 $63,308 - $70,638	-615 Reduced 7.71%	7,365 $784 Million
Q4 2022 Feb 14, 2023	BUY	$87.44 - $112.11 $697,771 - $894,637	7,980 New	7,980 $885 Million

3,820

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Alpha Q Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Q Advisors LLC with notifications on news.